Leap or lag: left atrial appendage closure and guidelines

por Camm, A John
Publicado 2023

Cardiology (Mainstream Medicine)

por Camm, A. John
Publicado 1990

A Colour Atlas of Adult Congenital Heart Disease

por Camm, A. John
Publicado 1990

In memory of Francesco Furlanello: a great advocate for dedicated commitment to effective, up-to-date, and expert management of cardiac arrhythmias and sports cardiology

por Boriani, Giuseppe, Camm, A John
Publicado 2023

Edoxaban: An Update on the New Oral Direct Factor Xa Inhibitor

por Bounameaux, Henri, Camm, A. John
Publicado 2014

Erratum to: Edoxaban: An Update on the New Oral Direct Factor Xa Inhibitor

por Bounameaux, Henri, Camm, A. John
Publicado 2014

Farewell from the founding editors of the European Heart Journal - Case Reports

por Camm, C Fielder, Camm, A John
Publicado 2023

European Heart Journal - Case Reports (EHJ-CR): a new format for an old concept

por Camm, C Fielder, Camm, A John
Publicado 2017

The cardiac effects of SARS-CoV2: COVID-19 special issue

por Camm, C Fielder, Camm, A John
Publicado 2020

Duplicate publication—what’s going up must come down

por Camm, Christian Fielder, Camm, A John
Publicado 2022

Strengths and weaknesses of ‘real-world’ studies involving non-vitamin K antagonist oral anticoagulants

por Camm, A John, Fox, Keith A A
Publicado 2018

Concomitant diabetes with atrial fibrillation and anticoagulation management considerations

por Kreutz, Reinhold, Camm, A John, Rossing, Peter
Publicado 2020

Managing atrial fibrillation in the global community: The European perspective

por Kaba, Riyaz A, Camm, A John, Williams, Timothy M, Sharma, Rajan
Publicado 2013

Managing thrombotic risk in patients with diabetes

por Camm, A. John, Sabbour, Hani, Schnell, Oliver, Summaria, Francesco, Verma, Atul
Publicado 2022

Cardiac Potassium Channels: Physiological Insights for Targeted Therapy

por Jeevaratnam, Kamalan, Chadda, Karan R., Huang, Christopher L.-H., Camm, A. John
Publicado 2017

Single Doses up to 800 mg of E-52862 Do Not Prolong the QTc Interval – A Retrospective Validation by Pharmacokinetic-Pharmacodynamic Modelling of Electrocardiography Data Utilising...

por Täubel, Jörg, Ferber, Georg, Lorch, Ulrike, Wang, Duolao, Sust, Mariano, Camm, A. John
Publicado 2015

Thorough QT study of the effect of intravenous amisulpride on QTc interval in Caucasian and Japanese healthy subjects

por Täubel, Jörg, Ferber, Georg, Fox, Gabriel, Fernandes, Sara, Lorch, Ulrike, Camm, A. John
Publicado 2016

A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology

por Arya, Anita, Silberbauer, John, Teichman, Sam L., Milner, Peter, Sulke, Neil, Camm, A. John
Publicado 2009

Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation

por Camm, A. John, Pinto, Fausto J., Hankey, Graeme J., Andreotti, Felicita, Hobbs, F.D. Richard
Publicado 2015

Cardiac effects of amiselimod compared with fingolimod and placebo: results of a randomised, parallel‐group, phase I study in healthy subjects

por Harada, Tomohiko, Wilbraham, Darren, de La Borderie, Guillemette, Inoue, Shinsuke, Bush, Jim, Camm, A. John
Publicado 2017